The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Norepinephrine Injection Market Research Report 2024

Global Norepinephrine Injection Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1765089

No of Pages : 91

Ask Your Query

Synopsis
Norepinephrine (NE), also called noradrenaline (NA) or noradrenalin, is an organic chemical in the catecholamine family that functions in the brain and body as a hormone and neurotransmitter.

Norepinephrine also called noradrenaline is both a hormone, produced by the adrenal glands, and a neurotransmitter, a chemical messenger which transmits signals across nerve endings in the body. Norepinephrine is produced in the inner part of the adrenal glands, also called the adrenal medulla. The adrenal medulla also makes adrenaline (also known as epinephrine).

Norepinephrine, adrenaline and dopamine belong are part of the catecholamine family. Adrenal glands are making primarily adrenaline and most of the norepinephrine in the blood comes from nerve endings. It plays a role in your mood and ability to concentrate.

Global Norepinephrine Injection market is projected to reach US$ 878.7 million in 2029, increasing from US$ 440 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Norepinephrine Injection market research.

Key manufacturers engaged in the Norepinephrine Injection industry include Pfizer, Novartis, Teva, Amneal Biosciences, Baxter, Mylan, Hikma Pharmaceuticals, Shanghai Harvest and Grand Pharmaceutical, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Norepinephrine Injection were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Norepinephrine Injection market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Norepinephrine Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • Pfizer
  • Novartis
  • Teva
  • Amneal Biosciences
  • Baxter
  • Mylan
  • Hikma Pharmaceuticals
  • Shanghai Harvest
  • Grand Pharmaceutical
  • King York

Segment by Type

  • 2mg
  • 4mg
  • Other

Segment by Application

  • Shock Hypotensive
  • AMI Hypotension
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

The Norepinephrine Injection report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

1 Norepinephrine Injection Market Overview
1.1 Product Overview and Scope of Norepinephrine Injection
1.2 Norepinephrine Injection Segment by Type
1.2.1 Global Norepinephrine Injection Market Value Comparison by Type (2023-2029)
1.2.2 2mg
1.2.3 4mg
1.2.4 Other
1.3 Norepinephrine Injection Segment by Application
1.3.1 Global Norepinephrine Injection Market Value by Application: (2023-2029)
1.3.2 Shock Hypotensive
1.3.3 AMI Hypotension
1.3.4 Other
1.4 Global Norepinephrine Injection Market Size Estimates and Forecasts
1.4.1 Global Norepinephrine Injection Revenue 2018-2029
1.4.2 Global Norepinephrine Injection Sales 2018-2029
1.4.3 Global Norepinephrine Injection Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Norepinephrine Injection Market Competition by Manufacturers
2.1 Global Norepinephrine Injection Sales Market Share by Manufacturers (2018-2023)
2.2 Global Norepinephrine Injection Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Norepinephrine Injection Average Price by Manufacturers (2018-2023)
2.4 Global Norepinephrine Injection Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Norepinephrine Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Norepinephrine Injection, Product Type & Application
2.7 Norepinephrine Injection Market Competitive Situation and Trends
2.7.1 Norepinephrine Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Norepinephrine Injection Players Market Share by Revenue
2.7.3 Global Norepinephrine Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Norepinephrine Injection Retrospective Market Scenario by Region
3.1 Global Norepinephrine Injection Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Norepinephrine Injection Global Norepinephrine Injection Sales by Region: 2018-2029
3.2.1 Global Norepinephrine Injection Sales by Region: 2018-2023
3.2.2 Global Norepinephrine Injection Sales by Region: 2024-2029
3.3 Global Norepinephrine Injection Global Norepinephrine Injection Revenue by Region: 2018-2029
3.3.1 Global Norepinephrine Injection Revenue by Region: 2018-2023
3.3.2 Global Norepinephrine Injection Revenue by Region: 2024-2029
3.4 North America Norepinephrine Injection Market Facts & Figures by Country
3.4.1 North America Norepinephrine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Norepinephrine Injection Sales by Country (2018-2029)
3.4.3 North America Norepinephrine Injection Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Norepinephrine Injection Market Facts & Figures by Country
3.5.1 Europe Norepinephrine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Norepinephrine Injection Sales by Country (2018-2029)
3.5.3 Europe Norepinephrine Injection Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Norepinephrine Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Norepinephrine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Norepinephrine Injection Sales by Country (2018-2029)
3.6.3 Asia Pacific Norepinephrine Injection Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Southeast Asia
3.7 Latin America Norepinephrine Injection Market Facts & Figures by Country
3.7.1 Latin America Norepinephrine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Norepinephrine Injection Sales by Country (2018-2029)
3.7.3 Latin America Norepinephrine Injection Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Norepinephrine Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Norepinephrine Injection Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Norepinephrine Injection Sales by Country (2018-2029)
3.8.3 Middle East and Africa Norepinephrine Injection Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Norepinephrine Injection Sales by Type (2018-2029)
4.1.1 Global Norepinephrine Injection Sales by Type (2018-2023)
4.1.2 Global Norepinephrine Injection Sales by Type (2024-2029)
4.1.3 Global Norepinephrine Injection Sales Market Share by Type (2018-2029)
4.2 Global Norepinephrine Injection Revenue by Type (2018-2029)
4.2.1 Global Norepinephrine Injection Revenue by Type (2018-2023)
4.2.2 Global Norepinephrine Injection Revenue by Type (2024-2029)
4.2.3 Global Norepinephrine Injection Revenue Market Share by Type (2018-2029)
4.3 Global Norepinephrine Injection Price by Type (2018-2029)
5 Segment by Application
5.1 Global Norepinephrine Injection Sales by Application (2018-2029)
5.1.1 Global Norepinephrine Injection Sales by Application (2018-2023)
5.1.2 Global Norepinephrine Injection Sales by Application (2024-2029)
5.1.3 Global Norepinephrine Injection Sales Market Share by Application (2018-2029)
5.2 Global Norepinephrine Injection Revenue by Application (2018-2029)
5.2.1 Global Norepinephrine Injection Revenue by Application (2018-2023)
5.2.2 Global Norepinephrine Injection Revenue by Application (2024-2029)
5.2.3 Global Norepinephrine Injection Revenue Market Share by Application (2018-2029)
5.3 Global Norepinephrine Injection Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Norepinephrine Injection Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Norepinephrine Injection Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Teva Norepinephrine Injection Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Amneal Biosciences
6.4.1 Amneal Biosciences Corporation Information
6.4.2 Amneal Biosciences Description and Business Overview
6.4.3 Amneal Biosciences Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amneal Biosciences Norepinephrine Injection Product Portfolio
6.4.5 Amneal Biosciences Recent Developments/Updates
6.5 Baxter
6.5.1 Baxter Corporation Information
6.5.2 Baxter Description and Business Overview
6.5.3 Baxter Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Baxter Norepinephrine Injection Product Portfolio
6.5.5 Baxter Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mylan Norepinephrine Injection Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Hikma Pharmaceuticals Norepinephrine Injection Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Shanghai Harvest
6.8.1 Shanghai Harvest Corporation Information
6.8.2 Shanghai Harvest Description and Business Overview
6.8.3 Shanghai Harvest Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Shanghai Harvest Norepinephrine Injection Product Portfolio
6.8.5 Shanghai Harvest Recent Developments/Updates
6.9 Grand Pharmaceutical
6.9.1 Grand Pharmaceutical Corporation Information
6.9.2 Grand Pharmaceutical Description and Business Overview
6.9.3 Grand Pharmaceutical Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Grand Pharmaceutical Norepinephrine Injection Product Portfolio
6.9.5 Grand Pharmaceutical Recent Developments/Updates
6.10 King York
6.10.1 King York Corporation Information
6.10.2 King York Description and Business Overview
6.10.3 King York Norepinephrine Injection Sales, Revenue and Gross Margin (2018-2023)
6.10.4 King York Norepinephrine Injection Product Portfolio
6.10.5 King York Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Norepinephrine Injection Industry Chain Analysis
7.2 Norepinephrine Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Norepinephrine Injection Production Mode & Process
7.4 Norepinephrine Injection Sales and Marketing
7.4.1 Norepinephrine Injection Sales Channels
7.4.2 Norepinephrine Injection Distributors
7.5 Norepinephrine Injection Customers
8 Norepinephrine Injection Market Dynamics
8.1 Norepinephrine Injection Industry Trends
8.2 Norepinephrine Injection Market Drivers
8.3 Norepinephrine Injection Market Challenges
8.4 Norepinephrine Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock